Type 1 diabetes trials in Japan

1 of 6 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus

  Where

  Aichi, Aomori, Chiba, Chitose, Hokkaido, Ehime, Fukuoka, Gifu, Gunma, Hiroshima, Hokkaido, Hyōgo, Hyogogoken, Ibaraki, Kagawa, Kagoshima-shi, Kagoshima, Kanagawa, Kisarazu-shi, Chiba, Koriyama-shi, Fukushima, Kumamoto, Kumamoto-shi, Kumamoto, Kyoto, Kyoto-shi, Kyoto, Mie, Mitaka-shi, Tokyo, Miyazaki, Muroran-shi, Hokkaido, Nagano, Nagasaki, Niigata, Numakunai, Ōita, Oita-shi, Oita,, Okayama, Okinawa, Osaka, Saga, Saitama, Sendai-shi, Miyagi, Shiga, Shimane, Shizuoka, Tamana-shi, Kumamoto, Tochigi, Tokushima, Tokyo, Tottori, Wakayama, Yamagata, Yamaguchi, Yamato-shi, Kanagawa

  People

  630

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT06807190